Basilea Pharmaceutica
BSLN.SW
#6328
Rank
S$0.82 B
Marketcap
$68.16
Share price
2.38%
Change (1 day)
12.62%
Change (1 year)

EPS for Basilea Pharmaceutica (BSLN.SW)

EPS in 2023: $1.36

According to Basilea Pharmaceutica's latest financial reports the company's current EPS (TTM) is $1.36. In 2023 the company made an earnings per share (EPS) of $1.36 a decrease over its 2022 EPS that were of $1.45.

EPS history for Basilea Pharmaceutica from 2002 to 2023

Annual EPS

Year EPS Change
2023$1.36-6.28%
2022$1.45-273.94%
2021-$0.83-60.87%
2020-$2.13-24.46%
2019-$2.81-26.92%
2018-$3.8559.83%
2017-$2.41-63.06%
2016-$6.52-19.26%
2015-$8.0846.12%
2014-$5.5310.07%
2013-$5.02-36.76%
2012-$7.94-5.42%
2011-$8.39-153.36%
2010$15.73-198.47%
2009-$15.98-15.34%
2008-$18.8716.7%
2007-$16.1736.07%
2006-$11.8879.07%
2005-$6.64-46.79%
2004-$12.479.83%
2003-$11.35-34.23%
2002-$17.26